Diffuse intrinsic pontine gliomas (DIPGs) are aggressive pediatric brain tumors for which there is currently no effective treatment. Some of these tumors combine gain-of-function mutations in ACVR1, PIK3CA, and histone H3-encoding genes. The oncogenic mechanisms of action of ACVR1 mutations are currently unknown. Using mouse models, we demonstrate that Acvr1 arrests the differentiation of oligodendroglial lineage cells, and cooperates with Hist1h3b and Pik3ca to generate high-grade diffuse gliomas. Mechanistically, Acvr1 upregulates transcription factors which control differentiation and DIPG cell fitness. Furthermore, we characterize E6201 as a dual inhibitor of ACVR1 and MEK1/2, and demonstrate its efficacy toward tumor cells in vivo. Collectively, our results describe an oncogenic mechanism of action for ACVR1 mutations, and suggest therapeutic strategies for DIPGs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105820 | PMC |
| http://dx.doi.org/10.1016/j.ccell.2020.02.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cell Senescence in Heterotopic Ossification.
Biomolecules
April 2024
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.
Article Synopsis
- Heterotopic ossification (HO) is the abnormal formation of bone outside the usual skeleton, caused by genetic mutations or acquired factors like injury and aging.
- Fibrodysplasia ossificans progressiva (FOP) is the most severe genetic form of HO, linked to specific mutations and characterized by relentless progression.
- Cellular senescence, a key feature of aging that contributes to HO, may present new treatment opportunities by targeting these senescent cells for both FOP and acquired HO.
BMP-ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B-Cell Lymphoma.
Adv Sci (Weinh)
March 2024
Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China.
EZH2 is the catalytic subunit of the histone methyltransferase Polycomb Repressive Complex 2 (PRC2), and its somatic activating mutations drive lymphoma, particularly the germinal center B-cell type. Although PRC2 inhibitors, such as tazemetostat, have demonstrated anti-lymphoma activity in patients, the clinical efficacy is not limited to EZH2-mutant lymphoma. In this study, Activin A Receptor Type 1 (ACVR1), a type I Bone Morphogenetic Protein (BMP) receptor, is identified as critical for the anti-lymphoma efficacy of PRC2 inhibitors through a whole-genome CRISPR screen.
View Article and Find Full Text PDFTP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.
Leukemia
January 2024
Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
We identified activin A receptor type I (ACVR1), a member of the TGF-β superfamily, as a factor favoring acute myeloid leukemia (AML) growth and a new potential therapeutic target. ACVR1 is overexpressed in FLT3-mutated AML and inhibition of ACVR1 expression sensitized AML cells to FLT3 inhibitors. We developed a novel ACVR1 inhibitor, TP-0184, which selectively caused growth arrest in FLT3-mutated AML cell lines.
View Article and Find Full Text PDFMutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.
Cancer Cell
March 2020
Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada. Electronic address:
Diffuse intrinsic pontine gliomas (DIPGs) are aggressive pediatric brain tumors for which there is currently no effective treatment. Some of these tumors combine gain-of-function mutations in ACVR1, PIK3CA, and histone H3-encoding genes. The oncogenic mechanisms of action of ACVR1 mutations are currently unknown.
View Article and Find Full Text PDFIncreased activity of mesenchymal ALK2-BMP signaling causes posteriorly truncated microglossia and disorganization of lingual tissues.
Genesis
January 2020
Department of Animal and Dairy Science, Regenerative Bioscience Center, College of Agricultural and Environmental Sciences, University of Georgia, Athens, Georgia.
Article Synopsis
- - The development of taste organs like the tongue involves crucial interactions with mesenchyme through various signaling pathways, particularly the bone morphogenetic proteins (BMPs) and their receptors, although their specific roles are still not fully understood.
- - In experiments with mice having enhanced ALK2-BMP signaling in the tongue mesenchyme, researchers observed microglossia, characterized by a smaller and misshapen tongue, along with other anatomical defects.
- - Findings indicate that increased ALK2-BMP signaling disrupts the normal development of the tongue's structure, affecting epithelial tissues, muscles, and nerves, and leading to specific deficiencies like missing circumvallate papillae and halted growth of other taste papillae.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!